<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Curated"><PMID Version="2">36973991</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1600-0846</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)</Title><ISOAbbreviation>Skin Res Technol</ISOAbbreviation></Journal><ArticleTitle>New concepts on abnormal UV reactions in systemic lupus erythematosus and a screening tool for assessment of photosensitivity.</ArticleTitle><Pagination><StartPage>e13247</StartPage><MedlinePgn>e13247</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13247</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/srt.13247</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corbin</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christian</LastName><ForeName>Lea</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapp</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Langni</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohan</LastName><ForeName>Craig A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-4268-4311</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (Dermatology), Dayton Veterans Administration Medical Center, Dayton, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Travers</LastName><ForeName>Jeffrey B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (Dermatology), Dayton Veterans Administration Medical Center, Dayton, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX000853</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES031087</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL062996</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL062996</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5I01BX000853</GrantID><Agency>Veteran's Administration Merit</Agency><Country/></Grant><Grant><GrantID>R01 ES031087</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Skin Res Technol</MedlineTA><NlmUniqueID>9504453</NlmUniqueID><ISSNLinking>0909-752X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010787" MajorTopicYN="Y">Photosensitivity Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014466" MajorTopicYN="Y">Ultraviolet Rays</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36973991</ArticleId><ArticleId IdType="mid">NIHMS1850379</ArticleId><ArticleId IdType="pmc">PMC10059080</ArticleId><ArticleId IdType="doi">10.1111/srt.13247</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update Omicron the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33051219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A, Gordon C, Crow MK, et&#xa0;al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.</Citation><ArticleIdList><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A, Chong BF. Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2013;29(1):4&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539182</ArticleId><ArticleId IdType="pubmed">23281691</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et&#xa0;al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400&#x2010;1412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall'Era M, Cisternas MG, Snipes K, Herrinton LJ, Gordon C, Helmick CG. The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: the California lupus surveillance project. Arthritis Rheumatol. 2017;69(10):1996&#x2010;2005.</Citation><ArticleIdList><ArticleId IdType="pubmed">28891237</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144&#x2010;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6026543</ArticleId><ArticleId IdType="pubmed">29251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P. Cutaneous manifestations of systemic lupus erythematosus. Autoimmune Dis. 2012;2012:834291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3410306</ArticleId><ArticleId IdType="pubmed">22888407</ArticleId></ArticleIdList></Reference><Reference><Citation>Filotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico&#x2010;pathologic correlation. G Ital Dermatol Venereol. 2018;153(2):216&#x2010;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">29368845</ArticleId></ArticleIdList></Reference><Reference><Citation>Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013;27(3):391&#x2010;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3927537</ArticleId><ArticleId IdType="pubmed">24238695</ArticleId></ArticleIdList></Reference><Reference><Citation>Doglio M, Alexander T, Del Papa N, et&#xa0;al. New insights in systemic lupus erythematosus: from regulatory T cells to CAR&#x2010;T&#x2010;cell strategies. J Allergy Clin Immunol. 2022;S0091&#x2010;6749:01056&#x2010;01059.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137815</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein B, Kunz M. Current concepts of photosensitivity in cutaneous lupus erythematosus. Front Med (Lausanne). 2022;9:939594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452788</ArticleId><ArticleId IdType="pubmed">36091671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp MG, Spandau DF, Simman R, Travers JB. Insulin&#x2010;like growth factor 1 receptor signaling is required for optimal ATR&#x2010;CHK1 kinase signaling in ultraviolet B (UVB)&#x2010;irradiated human keratinocytes. J Biol Chem. 2017;292(4):1231&#x2010;1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5270469</ArticleId><ArticleId IdType="pubmed">27979966</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuechle MK, Elkon KB. Shining light on lupus and UV. Arthritis Res Ther. 2007;9(1):101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860055</ArticleId><ArticleId IdType="pubmed">17284304</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Jang GB, Quach C, Liang C. Darkening with UVRAG. Autophagy. 2019;15(2):366&#x2010;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333458</ArticleId><ArticleId IdType="pubmed">30209981</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman E, Langowski JL, Owen&#x2010;Schaub L. Mad dogs, Englishmen and apoptosis: the role of cell death in UV&#x2010;induced skin cancer. Apoptosis. 2003;8(4):315&#x2010;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">12815274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Herrmann M, Kleber S, et&#xa0;al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 2006;54(3):939&#x2010;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">16511837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf SJ, Estadt SN, Theros J, et&#xa0;al. Ultraviolet light induces increased T cell activation in lupus&#x2010;prone mice via type I IFN&#x2010;dependent inhibition of T regulatory cells. J Autoimmun. 2019;103:102291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6708464</ArticleId><ArticleId IdType="pubmed">31248690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Wenzel J, Weyd H. Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin Rev Allergy Immunol. 2014;47(2):148&#x2010;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">24420508</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasset F, Frances C. Current concepts and future approaches in the treatment of cutaneous lupus erythematosus: a comprehensive review. Drugs. 2019;79(11):1199&#x2010;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">31228033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Sonntag M, Richter&#x2010;Hintz D, et&#xa0;al. Phototesting in lupus erythematosus: a 15&#x2010;year experience. J Am Acad Dermatol. 2001;45(1):86&#x2010;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">11423840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Sonntag M, Sunderkotter C, Lehmann P, Vestweber D, Ruzicka T. Upregulation of epidermal surface molecule expression in primary and ultraviolet&#x2010;induced lesions of lupus erythematosus tumidus. Br J Dermatol. 2002;146(5):801&#x2010;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">12000376</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel&#x2010;Koomen CA. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol. 2003;149(1):131&#x2010;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">12890206</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipman WD, Chyou S, Ramanathan A, et&#xa0;al. A protective Langerhans cell&#x2010;keratinocyte axis that is dysfunctional in photosensitivity. Sci Transl Med. 2018;10(454):eaap9527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6365282</ArticleId><ArticleId IdType="pubmed">30111646</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath H Jr. Ultraviolet&#x2010;A1 irradiation therapy for systemic lupus erythematosus. Lupus. 2017;26(12):1239&#x2010;1251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5593127</ArticleId><ArticleId IdType="pubmed">28480786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy Crispin M, Fuentes&#x2010;Duculan J, Gulati N, et&#xa0;al. Gene profiling of narrowband UVB&#x2010;induced skin injury defines cellular and molecular innate immune responses. J Invest Dermatol. 2013;133(3):692&#x2010;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3679916</ArticleId><ArticleId IdType="pubmed">23151847</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerner J, Chalmers SA, Friedman A, Putterman C. Fn14 deficiency protects lupus&#x2010;prone mice from histological lupus erythematosus&#x2010;like skin inflammation induced by ultraviolet light. Exp Dermatol. 2016;25(12):969&#x2010;976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127760</ArticleId><ArticleId IdType="pubmed">27305603</ArticleId></ArticleIdList></Reference><Reference><Citation>Skopelja&#x2010;Gardner S, An J, Tai J, et&#xa0;al. The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent. Sci Rep. 2020;10(1):7908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220927</ArticleId><ArticleId IdType="pubmed">32404939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar MK, Hile GA, Tsoi LC, et&#xa0;al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal&#x2010;derived interferon kappa. Ann Rheum Dis. 2018;77(11):1653&#x2010;1664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6185784</ArticleId><ArticleId IdType="pubmed">30021804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwerys BR, Hachulla E, Spertini F, et&#xa0;al. Down&#x2010;regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon alpha&#x2010;kinoid. Arthritis Rheum. 2013;65(2):447&#x2010;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">23203821</ArticleId></ArticleIdList></Reference><Reference><Citation>Stannard JN, Reed TJ, Myers E, et&#xa0;al. Lupus skin is primed for IL&#x2010;6 inflammatory responses through a keratinocyte&#x2010;mediated autocrine Type I interferon loop. J Invest Dermatol. 2017;137(1):115&#x2010;122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5183476</ArticleId><ArticleId IdType="pubmed">27646883</ArticleId></ArticleIdList></Reference><Reference><Citation>Greth W, Robbie GJ, Brohawn P, Hultquist M, Yao B. Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus. Immunotherapy. 2017;9(1):57&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28000522</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamashta M, Merrill JT, Werth VP, et&#xa0;al. Sifalimumab, an anti&#x2010;interferon&#x2010;alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double&#x2010;blind, placebo&#x2010;controlled study. Ann Rheum Dis. 2016;75(11):1909&#x2010;1916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5099191</ArticleId><ArticleId IdType="pubmed">27009916</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson ES, VP Werth. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus. Cytokine. 2015;73(2):326&#x2010;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">25767072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus erythematosus: update of therapeutic options part II. J Am Acad Dermatol. 2011;65(6):e195&#x2010;e213.</Citation><ArticleIdList><ArticleId IdType="pubmed">20800319</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovin BH, van Vollenhoven RF, Aranow C, et&#xa0;al. A multicenter, randomized, double&#x2010;blind, placebo&#x2010;controlled study to evaluate the efficacy and safety of treatment with sirukumab (CNTO 136) in patients with active lupus nephritis. Arthritis Rheumatol. 2016;68(9):2174&#x2010;2183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5129491</ArticleId><ArticleId IdType="pubmed">27110697</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck S, Hochreiter B, Schmid JA. Extracellular vesicles linking inflammation, cancer and thrombotic risks. Front Cell Dev Biol. 2022;10:859863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970602</ArticleId><ArticleId IdType="pubmed">35372327</ArticleId></ArticleIdList></Reference><Reference><Citation>Frommeyer TC, Gilbert MM, Brittain GV, et&#xa0;al. UVB&#x2010;induced microvesicle particle release and its effects on the cutaneous microenvironment. Front Immunol. 2022;13:880850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120817</ArticleId><ArticleId IdType="pubmed">35603177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozkocak DC, Phan TK, Poon IKH. Translating extracellular vesicle packaging into therapeutic applications. Front Immunol. 2022;13:946422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9420853</ArticleId><ArticleId IdType="pubmed">36045692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobarrez F, Fuzzi E, Gunnarsson I, et&#xa0;al. Microparticles in the blood of patients with SLE: size, content of mitochondria and role in circulating immune complexes. J Autoimmun. 2019;102:142&#x2010;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">31103269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullal AJ, Reich CF 3rd, Clowse M, et&#xa0;al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun. 2011;36(3&#x2010;4):173&#x2010;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">21376534</ArticleId></ArticleIdList></Reference><Reference><Citation>Winberg LK, Jacobsen S, Nielsen CH. Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes. Arthritis Res Ther. 2017;19(1):230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5646131</ArticleId><ArticleId IdType="pubmed">29041967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronnblom L, Alm GV, ML Eloranta. The type I interferon system in the development of lupus. Semin Immunol. 2011;23(2):113&#x2010;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">21292501</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Zhou Q, Fu T, et&#xa0;al. Circulating exosomes derived&#x2010;miR&#x2010;146a from systemic lupus erythematosus patients regulates senescence of mesenchymal stem cells. Biomed Res Int. 2019;2019:6071308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679864</ArticleId><ArticleId IdType="pubmed">31428639</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Awoyemi AA, Fahy KE, et&#xa0;al. Keratinocyte&#x2010;derived microvesicle particles mediate ultraviolet B radiation&#x2010;induced systemic immunosuppression. J Clin Invest. 2021;131(10):e144963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121517</ArticleId><ArticleId IdType="pubmed">33830943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihl JC, Rapp CM, Chen Y, Travers JB. UVB generates microvesicle particle release in part due to platelet&#x2010;activating factor signaling. Photochem Photobiol. 2016;92(3):503&#x2010;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426906</ArticleId><ArticleId IdType="pubmed">26876152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahy K, Liu L, Rapp CM, et&#xa0;al. UVB&#x2010;generated microvesicle particles: a novel pathway by which a skin&#x2010;specific stimulus could exert systemic effects. Photochem Photobiol. 2017;93(4):937&#x2010;942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494001</ArticleId><ArticleId IdType="pubmed">28039861</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark KL, Reed TJ, Wolf SJ, Lowe L, Hodgin JB, Kahlenberg JM. Epidermal injury promotes nephritis flare in lupus&#x2010;prone mice. J Autoimmun. 2015;65:38&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679658</ArticleId><ArticleId IdType="pubmed">26305061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Gensch K, Haust M, et&#xa0;al. Photoprotective effects of a broad&#x2010;spectrum sunscreen in ultraviolet&#x2010;induced cutaneous lupus erythematosus: a randomized, vehicle&#x2010;controlled, double&#x2010;blind study. J Am Acad Dermatol. 2011;64(1):37&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">21167404</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhage KG, Zhao R, Nakamura M. Advancements in the treatment of cutaneous lupus erythematosus and dermatomyositis: a review of the literature. Clin Cosmet Investig Dermatol. 2022;15:1815&#x2010;1831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9467686</ArticleId><ArticleId IdType="pubmed">36105749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Aberer E, Bata&#x2010;Csorgo Z, et&#xa0;al. S2k guideline for treatment of cutaneous lupus erythematosus &#x2013; guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2017;31(3):389&#x2010;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">27859683</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S&#x2010;1086S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18400738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter A, Lehmann P. Relevant new insights into the effects of photoprotection in cutaneous lupus erythematosus. Exp Dermatol. 2014;23(10):712&#x2010;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">24910084</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt E, Tony HP, Brocker EB, Kneitz C. Sun&#x2010;induced life&#x2010;threatening lupus nephritis. Ann N Y Acad Sci. 2007;1108:35&#x2010;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">17893968</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>